Sadaghdar H, Chelluri L, Bowles S A, Shapiro R
Department of Anesthesiology/Critical Care, University of Pittsburgh Medical Center, Presbyterian-University Hospital, USA.
Chest. 1995 May;107(5):1402-5. doi: 10.1378/chest.107.5.1402.
To determine the outcome of renal transplant recipients in an intensive care unit (ICU).
Prospective, cohort study.
Surgical ICU in a tertiary care hospital.
Consecutive adult renal transplant recipients admitted to an ICU.
Demographic data, underlying diseases, indications for admission to the ICU, number of prior kidney transplantations, duration of immunosuppression, duration of mechanical ventilation, length of stay in ICU and hospital, and ICU and hospital mortality were recorded. Seventy-one patients were included in the study. Twenty-seven patients were admitted to the surgical ICU immediately after renal transplantation surgery for postoperative monitoring (group 1). One patient died in this group. The remaining 44 patients were renal transplant recipients admitted to the surgical ICU with various complications (group 2). The mean posttransplant time in group 2 was 23 +/- 30 months. Seven patients died in group 2. The overall ICU mortality in this study was 11% and hospital mortality was 14%. The hospital mortality for postoperative patients (3.7% in group 1) was below the rate predicted based on the acute physiology and chronic health evaluation (APACHE II) score (15%). APACHE II score, duration of mechanical ventilation, and ICU length of stay were significantly higher among nonsurvivors. The ICU mortality among renal transplant recipients was higher than that of other patients (6%) admitted to the surgical ICU during the study period.
The ICU mortality of renal transplant recipients was twice that of general surgical ICU patients. The hospital mortality rate for recipients admitted immediately postoperatively to the ICU (group 1) was less than predicted by APACHE II.
确定重症监护病房(ICU)中肾移植受者的治疗结果。
前瞻性队列研究。
一家三级护理医院的外科ICU。
连续入住ICU的成年肾移植受者。
记录人口统计学数据、基础疾病、入住ICU的指征、既往肾移植次数、免疫抑制持续时间、机械通气持续时间、在ICU和医院的住院时间以及ICU和医院死亡率。71例患者纳入研究。27例患者在肾移植手术后立即入住外科ICU进行术后监测(第1组)。该组1例患者死亡。其余44例患者为因各种并发症入住外科ICU的肾移植受者(第2组)。第2组移植后的平均时间为23±30个月。第2组7例患者死亡。本研究的总体ICU死亡率为11%,医院死亡率为14%。术后患者的医院死亡率(第1组为3.7%)低于根据急性生理与慢性健康状况评分(APACHE II)预测的死亡率(15%)。非幸存者的APACHE II评分、机械通气持续时间和ICU住院时间显著更高。肾移植受者的ICU死亡率高于研究期间入住外科ICU的其他患者(6%)。
肾移植受者的ICU死亡率是普通外科ICU患者的两倍。术后立即入住ICU的受者(第1组)的医院死亡率低于APACHE II预测值。